Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000480233 | SCV000573831 | likely pathogenic | not provided | 2017-03-09 | criteria provided, single submitter | clinical testing | A variant that is likely pathogenic has been identified in the ATP1A2 gene. The c.882_897del16 variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The c.882_897del16 variant causes a frameshift starting with codon Glycine 295, changes this amino acid to a Tryptophan residue and creates a premature Stop codon at position 27 of the new reading frame, denoted p.Gly295TrpfsX27. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Therefore, the c.882_897del16 variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |